ImmunityBio, Inc. , a clinical-stage immunotherapy company, today announced positive results from its ANKTIVA (nogapendekin alfa inbakicept) clinical program in non-small cell lung cancer (NSCLC) ...
ImmunityBio, Inc. is upgraded to Buy reflecting improving Anktiva data & potential label expansions in NMIBC and NSCLC. Read ...
CK0804 is a first in class, CXCR4hi Treg therapeutic designed to preferentially traffic towards its ligand CXCL12 over ...
Stocktwits on MSN
IBRX garners retail attention on positive update in immunotherapy for lung cancer patients
The company said that responding patients lived longer overall, with a median survival of 16.2 months. ・The data come from ...
Blood eosinophil count at a specific threshold shows high sensitivity and specificity for diagnosing eosinophilic ...
An elevated neutrophil-to-lymphocyte ratio (NLR) is significantly associated with increased risk of depressive disorder (DD) ...
News-Medical.Net on MSN
Elevated neutrophil-to-lymphocyte ratio linked to depression and suicide risk
An elevated neutrophil-to-lymphocyte ratio (NLR) is significantly associated with increased risk of depressive disorder (DD) ...
ImmunityBio (IBRX) announced results from its Anktiva clinical program in non-small cell lung cancer based on two studies, ...
The Allahabad high court has held that a candidate placed on a waiting list has no absolute right to appointment and that a waiting list cannot be in existence for an indefinite period. The court held ...
ANKTIVA, in combination with an immune checkpoint inhibitor, has received accelerated approval from the Saudi Food and Drug ...
Hosted on MSN
Understanding absolute CD4 count and CD4 percentage
CD4 counts show how strong your immune system is; lower counts mean a weaker immune response. The CD4 percentage shows what part of your white blood cells are CD4 cells and helps check how strong your ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback